Biogen’s disappointing Leqembi performance and weak pipeline hurt future growth. Learn why BIIB stock is rated "sell" due to ...

Shares of Pharma-Bio Serv, Inc. (OTCMKTS:PBSV – Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.58 and traded as high ...

Wide-moat GE HealthCare, or GEHC, is a top three global leader in the medical imaging market. It has a firmly established footprint in hospitals and health networks around the world, and it is ...

Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.

Vaccine policy, Medicare drug negotiations, and a potential DTC advertising ban will all fall under Kennedy’s purview as HHS ...

It's time for us to pass this cost back to Big Pharma where it belongs,” Commissioner Cameron Davis said. “It's also time to not keep the burden on the shoulders of our taxpayers.” ...

Using money from the opioid settlement funds from big pharmaceutical companies, St. Johns County will partner with EPIC ...

Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...

Kim Gillan writes, As the 119th Congress gets to work, I’m hopeful that Montana’s Congressional Delegation will prioritize and support legislation that addresses the ever-growing cost of prescription ...

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...

Hims & Hers hit the bullseye with its Super Bowl ad, sparking a surge in clicks to its site.The ad also hit a nerve with the ...

For every $100 of dividends paid by the S&P 500, the bottom 493 companies contribute $94 but receive just $68 or reinvestment ...